Home Blog Page 150

Gorilla Technology Accelerates Execution Across its Asian AI Infrastructure Platform


– Recent capital raising supports the execution of signed and developing AI infrastructure programmes –
Yotta deployments progressing ahead of current internal schedules –
– Korat 200MW AI data-centre campus advances through power, engineering and customer engagement workstreams –

London, United Kingdom – Newsfile Corp. – July 21, 2026 – Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”), a global provider of AI-driven infrastructure, security intelligence and data solutions, today announced that the completion of its two recent bond financings, raising aggregate gross proceeds of $232 million, is enabling the Company to accelerate execution across its AI infrastructure programmes in India, Indonesia and Thailand. The most recent financing is being deployed principally towards the NeutraDC Batam programme while the earlier financing supports Gorilla’s equity contribution to the Yotta 2 programme.

Jay Chandan, Chairman and Chief Executive Officer of Gorilla Technology, said: “There has been considerable market attention on the financing instrument but a lack of focus on the signed commercial programme that the financing enables. What should shareholders focus on? Not the financing itself, but the hundreds of millions of dollars in annualized revenue those financings have made possible.

This is not capital raised in the hope that Gorilla will subsequently find a customer or identify a project. The customer contract is signed, the data-centre capacity has been secured and the deployment programme is moving into execution. The financing provides the capital required to connect those elements and begin delivery.

The market is entitled to scrutinise every financing. Management is equally responsible for explaining what that financing supports. In this case, our $125 million capital raise is helping Gorilla execute a signed contract representing approximately $2.5 billion of expected revenue over five years alongside separate financing offers covering approximately 70% of expected project costs.

Growth on this scale cannot be funded by rhetoric. It requires disciplined access to capital, strong counterparties and capital deployed against contracted demand. That is precisely what Gorilla is doing.

Capital is not the destination. It is the bridge between signed customer demand and revenue-generating infrastructure.

I will not allow short-term market volatility to distract us from the work in front of us. Our focus is deployment, revenue, cash generation and profitability. The bonds are a financing instrument. The measure of this management team will be the business we build with them.”

Bruce Bower, Chief Financial Officer of Gorilla Technology, said: “Across the two recent financings, Gorilla has secured approximately $232 million of long-term corporate capital to support the GPUaaS programme.

We continue to match corporate equity, project-level debt, asset-backed financing, and operating cash flows to the specific requirements and duration of each project.

As deployments become operational, our objective is to use the cash generated by the underlying projects to support subsequent phases of growth and progressively reduce the amount of corporate-level capital required.”

Indonesia: NeutraDC Batam Remains on Schedule

The NeutraDC Batam programme remains on schedule. The Company’s most recent financing provided the corporate equity capital required to make advance payments, secure committed data-centre capacity and commence equipment procurement, logistics, integration and mobilisation for the initial deployment phases.

The first phase is expected to be deployed in two tranches, with the initial tranche targeted for September 2026 and the second targeted for December 2026. The remaining contracted capacity is expected to be delivered during the first half of 2027.

Revenue is expected to commence as contracted capacity is deployed and accepted in accordance with the customer agreement.

The programme supports a signed five-year AI compute infrastructure contract representing approximately $2.5 billion of expected revenue, including approximately $1.3 billion from its first phase.

India: Yotta Deployments Advancing Ahead of Schedule

The Company’s earlier financing was raised principally to support Gorilla’s equity contribution to the Yotta 2 programme, which is structured to support the deployment of 20,736 next-generation GPUs in New Delhi, India. Deployment activities for Gorilla’s Yotta 1 and Yotta 2 programmes in India are progressing ahead of the Company’s current internal schedules.

For Yotta 1, the Company is advancing the installation, integration, networking and operational-readiness work required to bring the initial GPU infrastructure into service. The current programme comprises 640 high-performance servers with 5,120 GPUs.

Gorilla has funded the initial mobilisation and deployment expenditure for Yotta 1 from its existing cash resources. The Yotta 1 programme is expected to contribute approximately $500 million of revenue over five years. The 640 servers are expected to be built, shipped and deployed by end of August 2026.

Work on Yotta 2 is also advancing across engineering, site readiness, infrastructure architecture, equipment planning and deployment sequencing. The programme is structured to support the planned deployment of an additional 20,736 next-generation GPUs in Delhi and has an estimated project value of approximately $2.5 billion under the current commercial framework.

The progress across both programmes reflects increasingly close coordination between Gorilla, Yotta, equipment providers, integration teams and financing partners.

Why the Recent Financings Matter

Gorilla’s two recent financings raised capital that provides the corporate equity component required to unlock substantially larger project-level and asset-backed financing packages.

Large infrastructure programmes are not ordinarily financed with 100% project debt. Sponsors are required to contribute equity capital before lenders fund the balance. Gorilla’s recent financings provide that equity contribution against signed customer demand and defined deployment programmes.

The Company continues to progress separate debt financing offers covering approximately 70% of expected GPU, networking and related infrastructure costs for the NeutraDC Batam programme.

The latest bonds do not result in the automatic issuance of ordinary shares upon closing. The initial conversion price of approximately $25.48 per ordinary share represent a premium of approximately 52% to Gorilla’s closing share price on July 14, 2026, subject to reset mechanisms previously disclosed by the Company including a potential upward reset.

Thailand: Korat 200MW Campus Advances Towards Commercialisation

At full build-out and utilisation, the 200MW IT-load campus is expected to support approximately 100,000 to 110,000 next-generation GPU equivalents.

Based on current pricing and utilisation assumptions, the fully developed campus has an illustrative gross revenue potential of approximately $16 billion to $18 billion over five years.

This represents potential rather than contracted revenue and remains subject to customer contracting, financing, final equipment configuration, deployment timing and utilisation.

Gorilla is advancing discussions with prospective customers regarding phased capacity commitments and long-duration offtake arrangements.

Jay Chandan concluded: “The signed programmes and physical deployments that our financing efforts have enabled are the real story.

The recent financings provide the equity capital required to unlock much larger project-level financing packages across Batam and Yotta. Infrastructure programmes of this scale are not financed with rhetoric or 100% debt. They require sponsor capital, disciplined execution and contracted demand.

Across India and Indonesia, Gorilla is moving from contract to deployment. In Thailand, we are advancing the next major stage of our regional platform.

Short-term market volatility does not alter the contracts, the deployment schedules or the underlying commercial opportunity – and certainly not our focus. We will be judged by infrastructure delivered, customers activated, revenue generated, cash collected and sustainable profitability. That is where management’s attention will remain.”

About Gorilla Technology Group Inc.

Headquartered in London U.K., Gorilla is a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, IoT technology and data centres. We provide a wide range of solutions, including Smart City, Network, Video, Security Convergence and IoT, across select verticals of Government & Public Services, Manufacturing, Telecom, Retail, Transportation & Logistics, Healthcare and Education, by using AI and Deep Learning Technologies.

Our expertise lies in revolutionizing urban operations, bolstering security and enhancing resilience. We deliver pioneering products that harness the power of AI in intelligent video surveillance, facial recognition, license plate recognition, edge computing, post-event analytics and advanced cybersecurity technologies. By integrating these AI-driven technologies, we empower Smart Cities to enhance efficiency, safety and cybersecurity measures, ultimately improving the quality of life for residents.

For more information, please visit our website: Gorilla-Technology.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Gorilla’s actual results may differ from its expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, statements regarding the Company’s contracts with Yotta and NeutraDC Batam, including the expected timing and amount of revenues that may be generated thereunder and the timing of deployment of the servers and overall execution under the contracts, the Company’s ability to fund GPU purchases and related expenses, and the Company’s ability to achieve its development objectives for the Korat 200MW Campus, along with those other risks described under the heading “Risk Factors” in the Form 20-F Gorilla filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2026 and those that are included in any of Gorilla’s future filings with the SEC. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside of the control of Gorilla and are difficult to predict. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Gorilla undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Investor Relations Contact

Dave Gentry
RedChip Companies, Inc. for Gorilla Technology
1-407-644-4256
GRRR@redchip.com

The issuer is solely responsible for the content of this announcement.

About Gorilla Technology Group Inc.

CSTS Debuts PremierX™ Globally with High-Impact FIFA World Cup Final Celebrations in New York and Hong Kong

Premium entertainment brand maps out aggressive international expansion following a successful launch wrapping up the FIFA World Cup 2026.

NEW YORK and HONG KONG, July 21, 2026 /PRNewswire/ — CSTS Enterprises, an integrated media, entertainment, sports, and travel technology group, announced the global launch of its new premium entertainment brand, PremierX™. The debut was marked by dual high-profile activations over the FIFA World Cup Final weekend in New York and Hong Kong, drawing esteemed VIP guests and football fans. Notably, many attendees were flown to the final in New York by Connexus Travel, Greater China’s officially appointed agent for the FIFA World Cup 2026™ Official Hospitality Programme.

World Cup Finale Night by PremierX featured a headline performance by internationally-acclaimed rapper Rich the Kid
World Cup Finale Night by PremierX featured a headline performance by internationally-acclaimed rapper Rich the Kid

The launch of PremierX™ marks CSTS’ strategic expansion into premium live entertainment and experiential events, creating a platform combining world-class musical talent and immersive experiences designed for the next generation of global consumers. The brand introduces a novel business model driven by “Premium Content + Tier-1 Artists + Community Engagement + Exclusivity” to build unique, premium international live entertainment IPs. The event was more than just a market debut, it’s a core strategic move by PremierX™ to deepen its footprint in global live entertainment, integrating content creation, artist management, community engagement and commercial communication.

The flagship activation, World Cup Finale Night by PremierX™, was held simultaneously in New York and Hong Kong, drawing influential audiences of entertainment industry leaders, creators, trendsetters and football fans during the FIFA World Cup Final celebrations.

“PremierX™ represents a new chapter and concept for CSTS’ global entertainment ambitions, a unique unity of sports and live entertainment,” said Abel Zhao, CSTS Group CEO and Executive Director. “By bringing together premium talent, cultural relevance and community-driven experiences, we are creating a scalable platform that connects brands, creators and audiences through memorable entertainment moments.”

Debut Showcases PremierX™ Global Vision

In New York, World Cup Finale Night by PremierX™ took place at the renowned 00:00 Nightclub, bringing together premium entertainment and content creators in a celebration aligned with the world’s most-watched sporting event.

The night featured a headline performance by internationally-acclaimed rapper Rich the Kid, a core guest performer on Kanye West’s global tour, alongside top local New York DJs, supported by performances from DJ SFW and DJ Tone, creating an immersive evening of music, sport and culture.

In Hong Kong, the party took place at leading sports entertainment venue Zerve, bringing together fans, influencers and young professionals for an immersive viewing experience featuring local DJs Hyphen, Jasmine and Caxus, successfully combining the passion of global football with music, lifestyle and community engagement.

Strategic Platform for Global Entertainment Growth

The launch of PremierX™ reflects CSTS’ commitment to developing a new category of premium entertainment experiences that combine:

  • International music and celebrity talent
  • Large-scale cultural and sporting moments
  • Influencer and community engagement
  • Premium nightlife and experiential activations
  • Scalable global event IP development

The FIFA World Cup Final weekend served as the perfect launch platform, allowing PremierX™ to engage audiences during one of the most significant moments on the global sports and entertainment calendar.

The Future

Wrapping a successful World Cup as an official hospitality partner, Connexus and CSTS will build on the debut of PremierX™, accelerating its international expansion through experiences tied to major global sports, entertainment and cultural moments. The company will continue investing in artist partnerships, influencer collaborations and large-scale event production, to build a global ecosystem that connects entertainment, lifestyle and community engagement for audiences worldwide. The strong response to the FIFA World Cup Final weekend not only demonstrates the demand for curated premium experiences, but also reinforces confidence in the market potential of global youth entertainment.

About CSTS 
CSTS Enterprises is an integrated media, entertainment, sports, and travel technology group. The company develops and partners with intellectual properties and brands to deliver compelling experiences that connect with local and regional audiences across the world. In addition to its own initiatives, including Generation C and PremierX™, it collaborates with international IPs such as the FIFA World Cup, Formula 1, and Waterbomb.

CSTS integrates experiential marketing, tourism, data, and technology to deliver connected audience experiences. The company engages consumers across physical events and digital channels, working with clients to execute at scale across markets, turning complex activations into co-ordinated, measurable outcomes.


Two Million Downloads, One Commitment: Moomoo Malaysia Partners Squash Legend Datuk Nicol David to Invest in Malaysia’s Youth

  • Partnership with the Nicol David Organisation will support up to 500 students through education, sports and investment literacy programmes.

KUALA LUMPUR, Malaysia, July 21, 2026 /PRNewswire/ — Moomoo Securities Malaysia (“Moomoo MY”) today announced that it has surpassed two million downloads in Malaysia as it marks the milestone with a RM100,000 commitment to the Nicol David Organisation (NDO) to support youth education, sports development and investment literacy initiatives for students from underserved communities. The partnership reflects Moomoo Malaysia’s belief that as more Malaysians take their first step towards investing, more young people should have the opportunity to take their first step towards a brighter future.

Indy Lau, Chief Operating Officer of Moomoo Malaysia (left) and Datuk Nicol David, Founder of the Nicol David Organisation (right) at the MOU signing ceremony, where Moomoo Malaysia pledged to contribute RM100,000 to the Nicol David Organisation.
Indy Lau, Chief Operating Officer of Moomoo Malaysia (left) and Datuk Nicol David, Founder of the Nicol David Organisation (right) at the MOU signing ceremony, where Moomoo Malaysia pledged to contribute RM100,000 to the Nicol David Organisation.

Through a Memorandum of Understanding (MoU) signed with NDO, Moomoo Malaysia has committed RM100,000 to the Nicol David Organisation to support up to 500 students under NDO’s Smart Mooves programme. The programme is an initiative that provides young people from lower-income communities with access to sports, investment intelligence and personal development support across 20 public secondary schools in Kuala Lumpur and Penang. For every RM1,000 deposited by a new user, Moomoo Malaysia will contribute RM10 to NDO as part of the initiative.

While retail investing participation in Malaysia continues to grow, young Malaysians remain underrepresented in the investment landscape. According to Bursa Malaysia, investors aged 18 to 35 account for just 20% of the country’s active retail investor base. At the same time, studies have consistently highlighted persistent gaps in financial literacy among younger demographics, reinforcing the need for greater access to education, capability-building and long-term financial empowerment.

Investing in Malaysia’s Youth

This partnership reflects a shared belief between Moomoo Malaysia and the Nicol David Organisation that success — whether in sport, education or investing — is built on strong foundations, discipline, consistency and access to the right opportunities. NDO’s Smart Mooves programme, which focuses on students above 16, is a four-week curriculum that blends physical activity with investment education, equipping participants with essential money management and planning skills from an early age. By investing in young Malaysians today, both organisations hope to nurture a generation that is more confident, capable and prepared to pursue its ambitions.

“Two million downloads is more than a milestone for Moomoo Malaysia. It represents millions of Malaysians taking a step towards building their financial future,” said Indy Lau, Chief Operating Officer of Moomoo Malaysia. “As we celebrate this achievement, we wanted to create something meaningful that gives back to the community that has supported our growth. Through our partnership with the Nicol David Organisation, we hope to help more young Malaysians take their first step towards achieving their own ambitions, regardless of their background or circumstances.”

Founded by eight-time world squash champion Datuk Nicol David and Mariana De Reyes, the Nicol David Organisation is a non-profit foundation dedicated to empowering women, girls and boys through sport, education, mental health and community development. Through programmes such as Smart Mooves, Little Legends and Positive Play (+ Play), NDO supports children and families from underserved communities by providing the skills, knowledge and support systems needed to build brighter futures.

“We are deeply grateful to Moomoo Malaysia for its support of our mission to empower young people and help them realise their full potential,” said Datuk Nicol David, Founder of the Nicol David Organisation. “This partnership will create meaningful opportunities for students and families, while reinforcing the importance of education, resilience and lifelong learning. We look forward to seeing the positive impact it will have on the communities we serve.”

A Growing Platform for Malaysian Investors

The two-million-download milestone reflects Moomoo Malaysia’s growing position as one of the country’s leading digital investing platforms and highlights the increasing number of Malaysians seeking access to global markets, investing tools and financial education resources.

Today, investors on the Moomoo platform can access a broad range of investment products across multiple markets, including Malaysian stocks, U.S. stocks, Hong Kong stocks, stock options, REITs, warrants and fractional shares. These are complemented by advanced investing tools such as Moomoo AI, Level 2 market data and an active investor community designed to support informed investment decision-making.

The two-million download milestone follows Moomoo Malaysia’s recognition at the Bursa Malaysia Excellence Awards 2025, where it was named Second Runner-Up for Best Retail Equities Participating Organisation (Non-Investment Bank). The recognition reflects the company’s continued efforts to raise the standard of digital investing through technology, education and customer experience.

About Moomoo Malaysia

Moomoo Securities Malaysia Sdn. Bhd. (“Moomoo Malaysia”) is a Capital Markets Services Licence (Licence No. eCMSL/A0397/2024) holder. Moomoo Malaysia is a cutting-edge digital investment platform designed to empower investors of all levels with professional-grade tools, in-depth market data, and expert insights. As a subsidiary of a Nasdaq-listed company and global partner of the NYSE and Nasdaq, Moomoo Malaysia brings world-class financial technology to Malaysia.

Moomoo Malaysia is Malaysia’s No. 1 most downloaded financial app by downloads and daily active users. [1]

Dedicated to transforming the local investment scene, Moomoo Malaysia makes innovative trading tools and educational resources accessible to all investors, setting new standards in financial technology and reinforcing its position as the leading digital investment platform in the region.

Find out more at www.moomoo.com/my.

Investments involve risk. Full disclaimers at https://www.moomoo.com/my/support/topic9_37.

([1]) No.1 broker trading app in Malaysia based on cumulative download data from launch date to 30 September 2025 from the data.ai website.

Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia

SHANGHAI, July 21, 2026 /PRNewswire/ — Alebund Pharmaceuticals (Jiangsu) Limited (“Alebund” or the “Company”; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the first participant has been randomized and dosed in the global Phase IIb multi-regional clinical trial of AP306 in patients with hyperphosphatemia receiving maintenance hemodialysis (NCT06712654). The trial is being conducted at multiple clinical sites in the United States and China and is co-sponsored by Alebund and R1 Therapeutics, Inc. (“R1”).

AP306 (formerly known as EOS789) is a first-in-class oral pan-phosphate transporter inhibitor. AP306 was originally discovered and developed by Chugai Pharmaceutical Co., Ltd. (“Chugai”) and was subsequently licensed to the Company, which has obtained the global rights to develop, manufacture and commercialize AP306. Unlike conventional phosphate binders that bind phosphate in the gut lumen, AP306 broadly inhibits three key intestinal phosphate transporters — NaPi-IIb, PiT-1 and PiT-2 — to reduce active intestinal phosphate transport, offering a differentiated approach to the management of hyperphosphatemia. The randomization and dosing of the first participant marks a new stage in the multicenter clinical execution of AP306’s global development program in the United States and China.

Trial Design

The Phase IIb trial is a multicenter, randomized, double-blind, placebo-controlled study that plans to enroll approximately 168 participants with hyperphosphatemia receiving maintenance hemodialysis. Participants will be randomized across six fixed-dose AP306 regimens or placebo over an eight-week treatment period. The study is designed to evaluate the safety, tolerability and serum phosphate-lowering effect of fixed-dose AP306.

The primary endpoint is the change in serum phosphate from baseline to the end of treatment. Secondary endpoints include the proportion of participants reaching the target phosphate range and the time to phosphate control. Topline results are expected in the first half of 2027.

The trial has obtained approval from the Human Genetic Resources Administration of China (HGRAC). Peking University People’s Hospital, the China leading site, was recently activated, and participant enrollment is in progress.

Unmet Medical Need

Hyperphosphatemia is a common and important complication in patients with chronic kidney disease (CKD) receiving dialysis, affecting approximately 95% of dialysis-dependent CKD patients. Persistently elevated serum phosphate is associated with vascular calcification, secondary hyperparathyroidism, renal osteodystrophy, and increased risks of cardiovascular events and all-cause mortality. [1-3] Regular dialysis and dietary phosphate restriction are often insufficient to control phosphate burden, meaning patients frequently require long-term pharmacological treatment. Even with the widespread use of phosphate binders, approximately 76% of dialysis patients in China still fail to achieve the target serum phosphate range of 3.5–5.5 mg/dL, which is significantly higher than that in the U.S. (approx. 52%) and Japan (approx. 39%). [4-5] The number of dialysis patients in China is expected to grow from approximately 1.3 million in 2025 to about 3.4 million by 2035 (a CAGR of approx. 10.1%),  [6] representing a continuously expanding unmet medical need. Existing therapies still face challenges such as gastrointestinal tolerability, pill burden, and long-term adherence. Innovative treatment options that balance efficacy, tolerability, and convenience remain to be further developed.

Prior Phase II Study of AP306 in China

In a completed Phase II clinical trial in China (NCT05764590), AP306 monotherapy demonstrated a mean serum phosphate reduction from baseline of 2.51 mg/dL, compared with 1.08 mg/dL for the active comparator sevelamer carbonate. At Weeks 7 to 8, nearly 95% of patients in the AP306 group had serum phosphate levels below 5.5 mg/dL, compared with approximately 50% in the sevelamer carbonate group in the trial.

The most common adverse events were gastrointestinal disorders, mainly diarrhea; all diarrhea events were Grade 1 or 2 and mostly resolved within two weeks. No serious adverse event was reported in the AP306 group, and the discontinuation rate due to adverse events was below 5%. Results were published in Kidney International Reports. [7]

Based on AP306’s innovative mechanism and clinical results, the National Medical Products Administration granted Breakthrough Therapy Designation to AP306 for the treatment of hyperphosphatemia in patients with chronic kidney disease in June 2024.

References

[1] KDIGO 2017 Clinical Practice Guideline Update. Kidney Int Suppl. 2017;7(1):1–59.
[2] Block GA, et al. J Am Soc Nephrol. 2004;15(8):2208–2218.
[3] Tentori F, et al. Am J Kidney Dis. 2008;52(3):519–530.
[4] CIC, Global and Chinese Hyperphosphatemia Drug Industry Blue Book, 2023.
[5] Guedes M, et al. Kidney Med. 2023;5(2):100584. doi:10.1016/j.xkme.2022.100584.
[6] Prospectus of Alebund Pharmaceuticals (Jiangsu) Limited dated June 18, 2026
[7] Wang L, et al. Kidney Int Rep. 2025;10(4):1143–1151. doi:10.1016/j.ekir.2025.01.038. PMID: 40303220.

Collaboration with R1

R1 is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies for patients with kidney disease. In December 2025, Alebund and R1 entered into licensing and equity arrangements. Under the collaboration and license agreement forming part of these arrangements, Alebund granted R1 an exclusive license to develop, manufacture and commercialize AP306 outside Chinese Mainland, Hong Kong, Macau and Taiwan, while retaining full rights and control in those four markets. The parties are co-sponsors of the Phase IIb trial. Each party is responsible for clinical trial execution and regulatory submissions in its respective territory and provides the other party with relevant data and support required for regulatory purposes.

About Alebund Pharmaceuticals

Alebund Pharmaceuticals (09637.HK) is a biopharmaceutical company focused on kidney disease and related chronic conditions, aiming to bring better therapies to patients worldwide. It has one of the broadest renal-focused pipelines and an integrated platform spanning R&D, manufacturing and commercialization. Its portfolio comprises seven investigational drug candidates and one commercialized product, Mircera®. Three of the candidates are at the clinical stage: AP301 (Phase III; China registrational Phase III trial completed, global MRCT ongoing), AP306 (Phase II) and AP303 (Phase I). Together they address chronic kidney disease (CKD) and its complications, including hyperphosphatemia, renal anemia, IgA nephropathy, diabetic kidney disease, FSGS and ADPKD. Alebund has built a manufacturing site in Yangzhou, Jiangsu to support the future commercial manufacturing of AP301 and other pipeline products and has obtained a Drug Manufacturing License (Category B) issued by the Jiangsu Provincial Drug Administration. The Company has also established a dedicated nephrology sales team responsible for the commercialization of relevant products in China. For more information, visit www.alebund.com.

Media and Investor Inquiries

Media and Investor Relations: IR@alebund.com
Website: www.alebund.com

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements regarding clinical development plans, expected timing of data, product potential and future development. These statements are based on the Company’s judgments and assumptions as of the date of this press release and are subject to various risks and uncertainties; actual results may differ materially from such forward-looking statements. This press release does not constitute an offer to sell or a solicitation of an offer to purchase any securities.

The Art of Happiness: Nationwide Children’s Art Competition Celebrates Young Creativity in Vietnam

HO CHI MINH CITY, Vietnam, July 21, 2026 /PRNewswire/ — Young artists across Vietnam are invited to share what happiness means to them through The Art of Happiness: Painting Dreams, Discovering Worlds, a nationwide children’s art competition that celebrates imagination, creativity and personal expression. Co-organized by The Brand Promise and Lotus Gallery, and supported by Club Med and SERENE SAIGON, the initiative offers children a meaningful platform to tell their own stories of joy, hope and discovery through art.

Open to Vietnamese citizens and expatriates aged 08 to 18 residing in Vietnam, The Art of Happiness welcomes complimentary entries from all eligible participants. Through original artworks, young artists are invited to explore their own definition of happiness. In doing so, it encourages young artists to trust their creativity and express themselves with confidence.
Open to Vietnamese citizens and expatriates aged 08 to 18 residing in Vietnam, The Art of Happiness welcomes complimentary entries from all eligible participants. Through original artworks, young artists are invited to explore their own definition of happiness. In doing so, it encourages young artists to trust their creativity and express themselves with confidence.

Open to Vietnamese citizens and expatriates aged 8 to 18 residing in Vietnam, The Art of Happiness welcomes complimentary entries from all eligible participants. Through original artworks, young artists are invited to explore their own definition of happiness. In doing so, it encourages young artists to trust their creativity and express themselves with confidence.

Each participant may submit up to three artworks through the official registration platform from 20 July to 27 August 2026. From all submissions, 20 young artists will be selected as finalists to participate in a curated exhibition at Lotus Gallery, one of Ho Chi Minh City’s pioneering private art galleries established in 1991. Their selected artworks will be on display from 11 to 21 September 2026, giving them the opportunity to experience a professional gallery exhibition while engaging with art lovers, families and fellow young artists.

The collection will be open to the public, who will have the opportunity to vote for their favourite artworks and support emerging young talents. The initiative will culminate in an Award Ceremony on 21 September 2026, celebrating the creativity, imagination and unique perspectives of Vietnam’s next generation of young artists.

“The Art of Happiness is first and foremost about giving children space to explore what happiness means to them and to share those stories through art,” shared Bruno Courbet, Club Med’s Country Director for Thailand, India, Indonesia, and New Markets. “Every child experiences the world in a different way, and we wanted this initiative to become a platform where those diverse perspectives can be seen, appreciated and celebrated. We hope it inspires more young people to keep discovering, dreaming and expressing themselves, knowing that their voices and visions matter.”

Reflecting the philosophy behind the initiative, the prizes are designed to extend each young artist’s journey beyond the canvas. The Grand Prize offers one winning family of four a three-day, two-night all-inclusive stay at Club Med Phuket (excluding airfare), while the Second Prize provides another family with a stay and golf experience at SERENE SAIGON, a private clubhouse in Ho Chi Minh City. The Third Prize will offer a day pass at SERENE SAIGON for golf and lounge access. Additional award details will be announced prior to the exhibition.

For more information and the latest updates on the competition, visit Lotus Gallery’s official communication channel at www.facebook.com/lotusgalleryhcm.

Beijing Tong Ren Tang Sparks New Momentum in the Inheritance of TCM through Student Ambassador Programme

New Video Showcases the Younger Generation’s Journey from Campus into the World of TCM


To learn more about the students’ journey of discovery, please click the link below to watch the programme video on BTRT’s YouTube: https://youtu.be/6LRyk_DLucA

HONG KONG SAR – Media OutReach Newswire – 21 July 2026 – Beijing Tong Ren Tang Chinese Medicine Company Limited (“BTRT”) (3613.HK) has released a new video showcasing its Hong Kong “Student Ambassador Programme for Chinese Medicine and Health Care”, a youth engagement initiative designed to fuel young people’s interest in Traditional Chinese Medicine (TCM) through fresh, hands-on, and inspiring experiences.

This new video showcases Beijing Tong Ren Tang's Hong Kong
This new video showcases Beijing Tong Ren Tang’s Hong Kong “Student Ambassador Programme for Chinese Medicine and Health Care”, a youth engagement initiative designed to fuel young people’s interest in Traditional Chinese Medicine (TCM) through fresh, hands-on, and inspiring experiences.

Rooted in BTRT’s long-standing values and supported by the brand’s more than 350 years of history, the programme reflects the company’s commitment to promoting Chinese medicine culture while embracing innovation to connect with the next generation. Through immersive learning, 5G technology exploration and community activities, BTRT aims to make TCM more accessible, relevant and inspiring for primary and secondary school students in Hong Kong.

In the video, students share how they learned about the TCM principle of “preventive treatment of disease”, discovered how herbs can support daily wellness, and gained first-hand insight into the use of Chinese medicine therapies in sports recovery.

From classroom knowledge to real-world experience One of the programme’s key strengths is its ability to shape how students perceive TCM by showing its relevance to daily life, sparking curiosity, and encouraging continued conversations with peers and elders. During the visits to BTRT’s Hong Kong production and R&D base, students toured the Tong Ren Tang Museum, production plant, observed the production line, and joined a hands-on workshop to experience traditional pharmaceutical craftsmanship first-hand. Students also visited BTRT’s Chinese herbal garden, where they learned about the connection between Chinese medicine, nature and wellness.

Where Heritage meets Innovation and Technology The programme also introduces students to the role of innovation in modern Chinese medicine. During the visit to China Mobile 5G Innovation Centre Hong Kong Open Lab, students explored how 5G, AIoT and AI can support smarter health and wellness scenarios. Back on campus, they learned how connected sensors, communications technology and AI can be applied to Chinese herbal planting, from monitoring growth to collecting, analysing and presenting data.

Turning learning into community impact Student ambassadors also step into the community to serve as health mentors for the elderly, sharing wellness knowledge and supporting simple therapeutic activities such as Ba Duan Jin and acupoint-based care. They transform classroom learning into empathy, service and social responsibility.

Building a long-term platform for youth engagement As BTRT continues to grow in the region, the company sees youth education and cultural engagement as an important part of its long-term vision. The Student Ambassador Programme has now been extended into a long-term initiative, with this year marking its second year of rollout to nurture youngsters’ interest in Chinese medicine and health care.

Following the strong response to last year’s programme, it returns this year with its signature content, enhanced by the new “Campus Herbal Medicine Baizi Cabinet” initiative and visits to BTRT’s herbal garden, where students can learn about the link between Chinese medicine and nature, as well as the wisdom of seasonal wellness and balance. Together, these additions extend the programme’s impact, promote broader knowledge-sharing, and support the passing on of Chinese medicine culture across the campus community.

Guided by the vision of “Inheriting Traditional Chinese Medicine, Inspiring a Smarter Future,” BTRT remains committed to passing on the wisdom of Chinese medicine in ways that resonate with younger generations, while contributing its unique strengths to global health development.

Hashtag: #beijingtongrentang, #studentambassador, #TCM #traditionalChineseMedicine #BTRT


The issuer is solely responsible for the content of this announcement.

About Beijing Tong Ren Tang

Tong Ren Tang was founded in 1669 and has a 356-years history. The company has always adhered to its corporate motto of “No compromise on cost and labour despite the complexity of processing herbal medicine. No compromise on quality and standard despite the scarcity of medicine ingredients.” This commitment has led Beijing Tong Ren Tang to steady development, lasting through every generation, achieving excellence, and becoming a national treasure while expanding globally.

At the same time, Beijing Tong Ren Tang has taken on the mission of promoting traditional Chinese medicine culture, actively participating in domestic and international traditional Chinese medicine promotion activities, facilitating cultural exchanges around the world, and striving to expand the international influence of traditional Chinese medicine. To date, it has been operating over 160 retail branches in 26 countries and regions overseas, making it one of the most recognized traditional Chinese medicine brands internationally.

Tuya Smart Accelerates Physical AI Commercialization with Strategic Investment in Robopoet

HANGZHOU, China, July 21, 2026 /PRNewswire/ — Tuya Smart (NYSE: TUYA, HKEX: 2391), a leading global AI cloud platform service provider, made a strategic investment in Robopoet’s recently closed RMB 100 million pre-A financing round. The round also drew participation from existing backers Sequoia China and GSR Ventures, along with two other new investors. Tuya’s investment signals its accelerating push to close the commercialization loop for physical AI.


Behind the Investment: From AI Development to Global Expansion

Tuya’s strategic investment comes as Robopoet’s debut product Fuzozo has achieved cumulative domestic sales approaching 300,000 units as of June 2026. The two companies’ partnership dates to 2025, when Tuya began providing the underlying global AI cloud platform that helped transform this compact, plush, eye-blinking AI emotional companion into a market sensation.

“2026 marks the critical window for AI hardware to be commercialized at scale. Market-validated, AI-native hardware is entering a phase of explosive growth,” said Alex Yang, Co-founder, COO and CFO of Tuya Smart.

The strategic rationale goes beyond a bet on a single product category. It reflects a broader vision for AI hardware commercialization. As AI advances from models to real-world applications, AI hardware is emerging as a key bridge connecting the technology with consumers. From AI robots and toys to smart home devices, intelligent products are evolving into proactive AI companions. Through its AI+IoT ecosystem, Tuya will continue to drive the convergence of AI and the physical world.

Strong Market Validation of AI Toy Solutions

During the 618 Shopping Festival, China’s largest mid-year online shopping event, Tuya’s empowerment model proved its effectiveness at scale: Fuzozo sold 40,000 units, ranking first in Tmall’s AI toy category, while other Tuya-empowered AI Toy products collectively demonstrated ecosystem-wide momentum: Walulu sold 8,000 units; AOOMII Smart AI Companion Robot, AI Scruffy Cat and Wozzi each reached approximately 5,000 units in sales; and Famue landed on JD.com’s Smart Robot Gold List.

Despite their diverse forms and purposes, these products share a common foundation: Tuya provided critical support in either product innovation or market expansion. On the R&D side, Tuya AI Development Platform helped products rapidly navigate the journey from concept to mass production. On the market side, Tuya opened its localized operational resources and channel access capabilities, paving the way for brands like Fuzozo to enter the global market.

The breakout of these AI hardware products not only confirms that AI hardware is entering the public’s daily life but also validates the maturity and replicability of the AI hardware empowerment model.

Empowering Physical AI Innovation with Full-Stack AI Capability

Underpinning this push is a comprehensive full-stack AI toolkit designed to lower barriers for hardware developers. Tuya has deployed a suite of proprietary technologies including the Personal Voice Activity Detection (PVAD) model, Physical AI Foundation V2.8, WukongAI 3.0, T-RTC real-time communication network, Physical Action Model, and OmniMem V2.0 long-term memory system.

Looking ahead, Tuya will continue to open its global AI cloud platform capabilities and overseas resources to support AI hardware innovators and the emerging “One Person Company” model. Through strategic investments such as Robopoet, Tuya aims to build a new growth model centered on AI platform empowerment, ecosystem collaboration, and global commercialization of AI hardware innovations.

Lao Bullion Bank, MKS PAMP (Hong Kong) Sign MoU on Precious Metals Cooperation

On 20 July, Lao Bullion Bank (LBB) and MKS PAMP (Hong Kong) signed an agreement to cooperate on precious metals trading and connect Laos to international bullion markets. (Photo by LBB)

On 20 July, Lao Bullion Bank (LBB) and MKS PAMP (Hong Kong) signed an agreement to cooperate on precious metals trading and connect Laos to international bullion markets.

Chanthone Sitthixay, CEO of LBB, and Damien Han, Head of Sales for Asia Pacific at MKS PAMP (Hong Kong), signed the agreement in Vientiane. Santiphap Phomvihane, Lao Deputy Prime Minister and Minister of Finance, and The Honorable Christopher Hui, Hong Kong’s Secretary for Financial Services and the Treasury, attended the ceremony.

The two sides signed the MoU alongside a separate government-to-government agreement between the Lao Ministry of Finance and Hong Kong’s Financial Services and the Treasury Bureau on financial cooperation.

The agreement covers trading, refining, product distribution, technical cooperation, and knowledge exchange. It also allows both organisations to explore collaboration with the Laos-International Precious Metals Refinery (LIPMER), a facility central to Laos’ push to build out its domestic precious metals processing capacity.

MKS PAMP joined Shanghai Gold Exchange International as a founding participant in 2014. It has since taken part in regional milestones, including the first trade in SGE Hong Kong Contracts in 2025 and, in 2026, some of the earliest transactions through Hong Kong Precious Metals Central Clearing, among them one of the first HAU gold trades.

Han said the MoU comes at an important moment for financial cooperation between Laos and Hong Kong. He added that the framework would let both parties pursue cooperation linking Laos’ market development with international precious metals expertise and market practices.

LBB gave no timeline for implementing the cooperation areas the MoU outlines, and neither side disclosed financial terms.

The agreement builds on Laos’ broader effort to position itself in the regional precious metals trade, following the establishment of LIPMER and LBB’s own role in overseeing the sector domestically.

MKS PAMP trades, refines, and mints gold, silver, platinum, palladium, and other platinum group metals, and runs a refinery and mint in Switzerland. The LBMA and the LPPM both approve it as a Good Delivery Referee, one of three organizations worldwide with that status.